BRCA2 and pancreatic neoplasm: Overall, these data support that, in addition to synthetic lethality between POLQ and BRCA2, cytosolic DNA damage products that accumulate in the presence of POLQ inhibition activate cGAS-STING signaling in BRCA2-deficient pancreatic cancer cells.